Arm’s stock falls after earnings, showing how high the bar is for AI companies now
Arm says memory shortages could impact its business, but to a small degree.
Daily Spotlight: Reasonable Valuation for Stocks
Daily Spotlight: Reasonable Valuation for Stocks
Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.
Sunday's Election Prospects Weigh On The Yen
Sunday's Election Prospects Weigh On The Yen
Haelixa to advance DNA-based traceability tech with $2.3m funding
The funding round was led by returning investors Verve Ventures and Zurich Kantonalbank. It also saw participation from 212 Nex...
Novo Nordisk CEO tells investors to expect weight-loss drug pricing to go down before it comes back up
Recently-appointed CEO Mike Doustdar has repeatedly reset expectations since his arrival. Pricing and regulatory pressure is fierce an...
